State Street Corp Zentalis Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

A detailed history of State Street Corp transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 3,785,652 shares of ZNTL stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,785,652
Previous 4,417,056 14.29%
Holding current value
$15.5 Million
Previous $66.9 Million 10.84%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$10.83 - $16.49 $6.84 Million - $10.4 Million
-631,404 Reduced 14.29%
3,785,652 $59.7 Million
Q4 2023

Feb 14, 2024
BUY
$9.84 - $20.13 $16.9 Million - $34.5 Million
1,713,696 Added 63.39%
4,417,056 $66.9 Million
Q3 2023

Nov 14, 2023
SELL
$19.63 - $28.29 $8.82 Million - $12.7 Million
-449,554 Reduced 14.26%
2,703,360 $54.2 Million
Q2 2023

Aug 14, 2023
BUY
$17.41 - $30.05 $5.59 Million - $9.64 Million
320,891 Added 11.33%
3,152,914 $88.9 Million
Q1 2023

May 15, 2023
SELL
$16.14 - $24.94 $4.07 Million - $6.29 Million
-252,114 Reduced 8.17%
2,832,023 $48.7 Million
Q4 2022

Feb 14, 2023
BUY
$18.07 - $25.6 $4.23 Million - $5.99 Million
233,963 Added 8.21%
3,084,137 $62.1 Million
Q3 2022

Nov 15, 2022
SELL
$20.23 - $31.73 $5.45 Million - $8.55 Million
-269,560 Reduced 8.64%
2,850,174 $61.7 Million
Q2 2022

Aug 15, 2022
BUY
$17.91 - $52.25 $18.6 Million - $54.3 Million
1,039,294 Added 49.96%
3,119,734 $87.7 Million
Q1 2022

May 16, 2022
BUY
$41.58 - $80.89 $30.5 Million - $59.4 Million
734,024 Added 54.52%
2,080,440 $96 Million
Q4 2021

Feb 14, 2022
BUY
$66.92 - $84.79 $3.62 Million - $4.59 Million
54,153 Added 4.19%
1,346,416 $113 Million
Q3 2021

Nov 15, 2021
SELL
$46.83 - $73.5 $2.2 Million - $3.46 Million
-47,077 Reduced 3.51%
1,292,263 $86.1 Million
Q2 2021

Aug 16, 2021
SELL
$37.41 - $62.25 $4.86 Million - $8.08 Million
-129,851 Reduced 8.84%
1,339,340 $71.3 Million
Q1 2021

May 17, 2021
BUY
$35.69 - $52.72 $20.6 Million - $30.5 Million
577,682 Added 64.8%
1,469,191 $63.7 Million
Q4 2020

Feb 16, 2021
BUY
$31.71 - $57.97 $23.1 Million - $42.3 Million
729,915 Added 451.7%
891,509 $46.3 Million
Q3 2020

Nov 10, 2020
BUY
$27.03 - $47.97 $657,477 - $1.17 Million
24,324 Added 17.72%
161,594 $5.28 Million
Q2 2020

Aug 14, 2020
BUY
$23.2 - $54.8 $3.18 Million - $7.52 Million
137,270 New
137,270 $6.59 Million

Others Institutions Holding ZNTL

# of Institutions
142
Shares Held
76.3M
Call Options Held
68.2K
Put Options Held
2.3K
View Full List

About Zentalis Pharmaceuticals, Inc.

ZNTL Quotes by TradingView
  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $233M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email